Peregrine Asset Advisers’s Johnson & Johnson JNJ Stock Holding History

Peregrine Asset Advisers’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.67M	Sell	10,497 -54	-0.5%	-$12.6K	0.58%	49
2026 Q1	$2.58M	Sell	10,551 -20,889	-66%	-$4.87M	0.69%	42
2025 Q4	$6.51M	Buy	31,440 +21,032	+202%	+$4.16M	1.84%	17
2025 Q3	$1.93M	Buy	10,408 +6	+0.1%	+$1.03K	0.58%	50
2025 Q2	$1.59M	Buy	10,402 +13	+0.1%	+$2K	0.5%	52
2025 Q1	$1.72M	Sell	10,389 -257	-2%	-$40.2K	0.64%	45
2024 Q4	$1.54M	Sell	10,646 -1,594	-13%	-$247K	0.57%	51
2024 Q3	$1.98M	Buy	12,240 +105	+0.9%	+$16.7K	0.68%	43
2024 Q2	$1.77M	Buy	12,135 +6	+0%	+$892	0.7%	42
2024 Q1	$1.92M	Sell	12,129 -189	-2%	-$30.1K	0.77%	37
2023 Q4	$1.93M	Sell	12,318 -4	-0%	-$613	0.94%	34
2023 Q3	$1.92M	Buy	12,322 +10,993	+827%	+$1.81M	1%	26
2023 Q2	$220K	Buy	1,329 +6	+0.5%	+$968	0.17%	68
2023 Q1	$205K	Buy	1,323 +6	+0.5%	+$969	0.2%	63
2022 Q4	$233K	Sell	1,317 -89	-6%	-$15.4K	0.25%	51
2022 Q3	$230K	Buy	1,406 +6	+0.4%	+$1.01K	0.27%	52
2022 Q2	$248K	Buy	1,400 +5	+0.4%	+$891	0.18%	70
2022 Q1	$247K	Buy	1,395 +5	+0.4%	+$851	0.13%	95
2021 Q4	$238K	Buy	1,390 +6	+0.4%	+$982	0.1%	112
2021 Q3	$224K	Sell	1,384 -1,594	-54%	-$272K	0.11%	114
2021 Q2	$490K	Buy	2,978 +5	+0.2%	+$828	0.22%	69
2021 Q1	$489K	Sell	2,973 -1,275	-30%	-$206K	0.25%	65
2020 Q4	$669K	Buy	4,248 +5	+0.1%	+$738	0.31%	66
2020 Q3	$632K	Sell	4,243 -1,795	-30%	-$266K	0.35%	55
2020 Q2	$849K	Buy	6,038 +1,506	+33%	+$219K	0.48%	41
2020 Q1	$595K	Sell	4,532 -7,364	-62%	-$1.04M	0.45%	42
2019 Q4	$1.74K	Buy	11,896 +7,094	+148%	+$962K	0.4%	43
2019 Q3	$621K	Buy	4,802 +207	+5%	+$27.3K	0.35%	53
2019 Q2	$640K	Sell	4,595 -16	-0.3%	-$2.21K	0.33%	61
2019 Q1	$645K	Buy	4,611 +213	+5%	+$28.5K	0.37%	55
2018 Q4	$568K	Sell	4,398 -27	-0.6%	-$3.77K	0.74%	27
2018 Q3	$611K	Buy	4,425 +275	+7%	+$36.5K	0.28%	57
2018 Q2	$504K	Buy	4,150 +126	+3%	+$15.7K	0.26%	62
2018 Q1	$516K	Buy	4,024 +6	+0.1%	+$811	0.34%	44
2017 Q4	$561K	Buy	4,018 +387	+11%	+$53.9K	0.28%	54
2017 Q3	$472K	Sell	3,631 -35,449	-91%	-$4.7M	0.25%	52
2017 Q2	$5.17M	Buy	39,080 +35,255	+922%	+$4.5M	3.3%	7
2017 Q1	$477K	Buy	3,825 +6	+0.2%	+$717	0.26%	46
2016 Q4	$440K	Buy	3,819 +7	+0.2%	+$809	0.26%	59
2016 Q3	$450K	Buy	3,812 +194	+5%	+$23.5K	0.28%	56
2016 Q2	$439K	Sell	3,618 -994	-22%	-$113K	0.29%	58
2016 Q1	$499K	Buy	4,612 +7	+0.2%	+$725	0.38%	51
2015 Q4	$473K	Buy	4,605 +7	+0.2%	+$704	0.41%	50
2015 Q3	$429K	Sell	4,598 -35	-0.8%	-$3.39K	0.44%	42
2015 Q2	$453K	Sell	4,633 -79	-2%	-$7.91K	0.34%	57
2015 Q1	$474K	Buy	4,712 +5	+0.1%	+$508	0.31%	71
2014 Q4	$492K	Buy	4,707 +7	+0.1%	+$738	0.35%	70
2014 Q3	$501K	Sell	4,700 -26,669	-85%	-$2.77M	0.41%	58
2014 Q2	$3.28M	Buy	31,369 +26,786	+584%	+$2.71M	2.96%	9
2014 Q1	$450K	Sell	4,583 -93	-2%	-$8.62K	0.35%	61
2013 Q4	$429K	Buy	4,676 +6	+0.1%	+$553	0.37%	57
2013 Q3	$405K	Sell	4,670 -193	-4%	-$17.3K	0.39%	62
2013 Q2	$417K	Buy	+4,863	New	+$413K	0.43%	62

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Peregrine Asset Advisers's JNJ Position: Q2 2026 in Review

Peregrine Asset Advisers reduced its Johnson & Johnson (JNJ) stake by 0.51% in Q2 2026, selling an estimated $12.6K and leaving 10,497 shares worth $2.67M. The position accounts for 0.58% of the portfolio, ranked #49.

Peregrine Asset Advisers first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.51M in Q4 2025. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Peregrine Asset Advisers held 10,497 shares of Johnson & Johnson worth $2.67M as of Q2 2026.
Peregrine Asset Advisers sold 54 Johnson & Johnson shares in Q2 2026, an estimated $12.6K.
Johnson & Johnson made up 0.58% of Peregrine Asset Advisers's portfolio in Q2 2026, its #49 holding.
Peregrine Asset Advisers first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
Peregrine Asset Advisers's Johnson & Johnson position peaked at $6.51M in Q4 2025.
4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Peregrine Asset Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.